During the past decade, Arch Health Partners conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Arch Health Partners" are "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Cardiovascular Disease" (1 trials), "Dry Eye Disease" (1 trials) and "Dry Eye Syndromes" (1 trials). Many other conditions were trialed in "Arch Health Partners" in a lesser frequency.

Most popular intervention types in "Arch Health Partners" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials), "KPI-121 0.25% Ophthalmic Suspension" (1 trials) and "KPI-121 1% Ophthalmic Suspension dosed BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arch Health Partners" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Arch Health Partners". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Arch Health Partners, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arch Health Partners, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".